Journal of Enzyme Inhibition and Medicinal Chemistry · 2008 · 119 citations · 14 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyDrug DiscoveryEnzymologyDiabetes ManagementDiabetes PharmacotherapyEnzyme InhibitionGastrointestinal PharmacologyAnthocyanin ChemistryMixed InhibitionMixed-type Inhibitors
Cyanidin-3-galactoside, a natural anthocyanin, was investigated for its alpha-glucosidase inhibitory activity. The IC(50) value of cyanidin-3-galactoside was 0.50 +/- 0.05 mM against intestinal sucrase. A low dose of cyanidin-3-galactoside showed a synergistic inhibition on intestinal alpha-glucosidase (maltase and sucrase) when combined with acarbose. A kinetic analysis showed that cyanidin-3-galactoside gave a mixed type inhibition against intestinal sucrase. The results indicated that cyanidin-3-galactoside was an alpha-glucosidase inhibitor and could be used in combination with acarbose for treatment of diabetes.
14
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis et al. · The Lancet · 2002 · 2.5K citations